Exagen, Inc. (XGN)
4.13
-0.28
(-6.35%)
USD |
NASDAQ |
Nov 13, 16:00
4.125
0.00 (0.00%)
After-Hours: 19:59
Exagen Market Cap : 104.99M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 104.99M |
| November 12, 2026 | 112.10M |
| November 11, 2026 | 127.99M |
| November 10, 2026 | 133.71M |
| November 09, 2026 | 180.48M |
| November 06, 2026 | 147.69M |
| November 05, 2026 | 193.19M |
| November 04, 2026 | 205.88M |
| November 03, 2026 | 201.77M |
| November 02, 2026 | 202.98M |
| October 30, 2026 | 207.82M |
| October 29, 2026 | 210.48M |
| October 28, 2026 | 203.22M |
| October 27, 2026 | 188.22M |
| October 26, 2026 | 180.72M |
| October 23, 2026 | 175.88M |
| October 22, 2026 | 180.96M |
| October 21, 2026 | 190.64M |
| October 20, 2026 | 179.27M |
| October 19, 2026 | 179.75M |
| October 16, 2026 | 186.77M |
| October 15, 2026 | 207.09M |
| October 14, 2026 | 203.71M |
| October 13, 2026 | 205.16M |
| October 12, 2026 | 199.59M |
| Date | Value |
|---|---|
| October 09, 2026 | 203.71M |
| October 08, 2026 | 197.66M |
| October 07, 2026 | 200.80M |
| October 06, 2026 | 198.14M |
| October 05, 2026 | 204.67M |
| October 02, 2026 | 197.66M |
| October 01, 2026 | 190.88M |
| September 30, 2026 | 196.69M |
| September 29, 2026 | 200.80M |
| September 28, 2026 | 205.16M |
| September 25, 2026 | 210.96M |
| September 24, 2026 | 211.45M |
| September 23, 2026 | 206.85M |
| September 22, 2026 | 211.45M |
| September 21, 2026 | 208.54M |
| September 18, 2026 | 203.46M |
| September 17, 2026 | 190.40M |
| September 16, 2026 | 188.22M |
| September 15, 2026 | 181.21M |
| September 14, 2026 | 177.82M |
| September 11, 2026 | 170.08M |
| September 10, 2026 | 168.63M |
| September 09, 2026 | 176.85M |
| September 08, 2026 | 176.61M |
| September 04, 2026 | 183.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Myriad Genetics, Inc. | 541.66M |
| BioRestorative Therapies, Inc. | 1.898M |
| CareDx, Inc. | 4.086B |
| Natera, Inc. | 46.06B |
| Sera Prognostics, Inc. | 79.88M |
Market Cap Related Metrics
| PS Ratio | 1.377 |
| Price to Book Value | 7.622 |
| Price | 4.13 |
| Earnings Yield | -18.20% |